Overview
The patients with cognitive impairment after stroke were divided into control group, electroacupuncture group, olfactory therapy group, and electroacupuncture combined with olfactory therapy group, with 35 people in each group. After the end of the treatment, the clinical efficacy was evaluated.
Description
The patients with cognitive impairment after stroke were divided into control group, electroacupuncture group, olfactory therapy group, and electroacupuncture combined with olfactory therapy group, with 35 people in each group. All patients were treated with conventional drugs and general supportive treatment, and on the basis of this, the electroacupuncture group was given electroacupuncture treatment at bilateral Fengchi and Gongxue, the smell suction therapy group was given the intervention of volatile oil nasal suction of Acorus calamus, and the electroacupuncture group combined with smell and suction therapy group was given electroacupuncture treatment at the same time as the electroacupuncture treatment of bilateral Fengchi and Gongxue. After the 1 month innervation,the main efficacy indicators: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Barthel Index (MBI) score, and the secondary efficacy indicators: Transcranial Doppler (TCD), near-infrared functional brain imaging , magnetic resonance examination， the heart rate,blood pressure and the State Trait Anxiety Inventory （STAI）are collected.
Eligibility
Inclusion Criteria:
- (1) Comply with the diagnostic standards of Chinese medicine and Western medicine; (2) Meet the above MMSE and MoCA scale scoring criteria; (3) There is no gender limit, and the age is less than 70 years old; (4) No history of mental illness, clear consciousness, stable vital signs, can cooperate with the completion of the scale filling; (5) Patients with a diagnosis of cerebral infarction (or cerebral hemorrhage) in the recovery period within 6 months after stroke; (6) The patient or his/her family members sign the informed consent form (7）At the same time, healthy people without disease were recruited, and the inclusion criteria were no obvious disease history.
Exclusion Criteria:
- (1) Author of transient cerebral ischemia; (2) Patients with subarachnoid hemorrhage; (3) History of malignant diseases in the past; (4) Previous history of mental illness; (5) Previous history of epilepsy; (6) Previous history of asthma and obstructive pulmonary disease; (7) The patient's cognitive impairment occurred before stroke; (8) Those with severe communication difficulties; (9) The age of the patient is higher than or equal to 70 years old; (10) Admitted to the hospital and diagnosed as the sequelae of cerebral infarction (or cerebral hemorrhage) (the course of the disease is greater than 6 months); (11) Those who abuse drugs and drink a lot.